Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Breast cancer recurrence rates are lower with aromatase inhibitors than with tamoxifen, according to meta-analyses published online by the Journal of Clinical Oncology.…
Margaret McHugh, MD, MPH, Associate Professor at NYU School of Medicine, Director of Adolescent Clinic and Child Protection Team, Bellevue Hospital, Consultant at The Door Adolescent Service in…
Margaret McHugh, MD, MPH, Associate Professor at NYU School of Medicine, Director of Adolescent Clinic and Child Protection Team, Bellevue Hospital, discusses child neglect versus physical injury. Neglect…
NEW YORK (Reuters Health) – For a palpable breast mass with benign features on ultrasound, short-term follow-up is a reasonable alternative to immediate biopsy, particularly in a young…
NEW YORK (Reuters Health) – Treating HER-2 positive, metastatic breast cancer with trastuzumab significantly increased survival in a retrospective study, to the point were such women given the…
NEW YORK (Reuters Health) – New research confirms that tubular carcinoma (TC) of the breast has an excellent prognosis and goes on to show that outcomes are better…
NEW YORK (Reuters Health) – For pregnant women who require chronic anticoagulation, low molecular weight heparin (LMWH) is an alternative to warfarin, but not an ideal one, according…
NEW YORK (Reuters Health) – Cervical cancer screening should begin when a woman turns 21, according to newly revised evidence-based guidelines issued November 20 by the American College…
NEW YORK (Reuters Health) – In an update to its 2002 guidelines, the US Preventive Services Task Force (USPSTF) is now recommending that mammographic screening for breast cancer…
NEW YORK (Reuters Health) – After breast-conserving surgery for invasive cancer, mammographic density is a risk factor for local recurrence, particularly in women who don’t undergo radiotherapy, investigators…
